Non–carbapenemase-producing carbapenem-resistant Enterobacterales (CRE) isolates are the most common mechanism of CRE in the United States, but the optimal antimicrobial treatment remains to be elucidated.
Sunish Shah, PharmD, BCIDP
Advertisement
Sunish Shah, PharmD, BCIDP, is a board-certified infectious diseases pharmacist at the University of Pittsburgh Medical Center. His research interests include management of drug-resistant bacterial infections, antimicrobial pharmacokinetics, and pharmacotherapy for the treatment of respiratory viruses.
Articles by Sunish Shah, PharmD, BCIDP
Here is a review the mechanisms that lead to resistance, including risk factors.
Advertisement
Latest Updated Articles
An Overview of Cefiderocol Resistance Among Clinical PathogensPublished: October 20th 2021 | Updated:
A No-Carb Diet: An Overview of Non–Carbapenemase-Producing Carbapenem-Resistant EnterobacteralesPublished: January 14th 2026 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
CDC ACIP Workgroup Reviewing FDA-Approved HPV Vaccines
2
Measles Update: January 30, 2026
3
Top Infectious Disease News Stories Week of January 24 - January 30
4
AAP Releases its Recommended 2026 Childhood and Adolescent Immunization Schedule
5